V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1)

[Edit]

B7-H4; B7H4; B7S1; B7X; B7h.5; VCTN1; T-cell costimulatory molecule B7x; Immune costimulatory protein B7-H4

V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1)
B7H4 belongs to the B7 family of costimulatory proteins. These proteins are expressed on the surface of antigen-presenting cells and interact with ligands on T lymphocytes.
The predicted 282-amino acid protein, which is 87% identical to the mouse protein, contains a 2-amino acid intracellular domain, a large hydrophobic type I transmembrane region, and an extracellular domain with several N-glycosylation sites and conserved cysteine residues. Northern blot analysis revealed expression of a 1.8-kb transcript in spleen, lung, and thymus, and RT-PCR analysis detected expression in a wide range of tissues. Immunohistochemical and flow cytometric analyses showed expression on activated but not fresh T cells, B cells, monocytes, and dendritic cells.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPK032Hu01 Recombinant V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPK032Hu02 Recombinant V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPK032Hu03 Recombinant V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAK032Hu01 Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC; IP.
LAK032Hu71 Biotin-Linked Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC.
LAK032Hu81 FITC-Linked Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC; IF.
MAK032Hu21 Monoclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC; IP.
PAK032Hu02 Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC; IP.
PAK032Hu03 Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) WB; IHC; ICC; IP.
Assay Kits SEK032Hu ELISA Kit for V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) CLIA Kit Customized Service Offer
n/a ELISA Kit for V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) CLIA Kit Customized Service Offer
n/a ELISA Kit for V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) ELISA Kit Customized Service Offer
  1. "B7-H4, a molecule of the B7 family, negatively regulates T cell immunity."Immunity 18:849-861(2003) [PubMed] [Europe PMC] [Abstract] and Prostate.
  2. "Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family."J. Immunol. 171:4650-4654(2003) [PubMed] [Europe PMC] [Abstract]
  3. "The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation."Exp. Cell Res. 306:128-141(2005) [PubMed] [Europe PMC] [Abstract]
  4. "B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma."J. Exp. Med. 203:871-881(2006) [PubMed] [Europe PMC] [Abstract]
  5. "Induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells."J. Immunol. 177:40-44(2006) [PubMed] [Europe PMC] [Abstract]
  6. "B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival."Proc. Natl. Acad. Sci. U.S.A. 103:10391-10396(2006) [PubMed] [Europe PMC] [Abstract]
  7. "Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma."Cancer Res. 67:8900-8905(2007) [PubMed] [Europe PMC] [Abstract]
  8. "B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration."Gynecol. Oncol. 106:119-127(2007) [PubMed] [Europe PMC] [Abstract]